INBS
Intelligent Bio·NASDAQ
--
--(--)
--
--(--)
INBS fundamentals
Intelligent Bio (INBS) Revenue Breakdown: Q2 2026 Business & Regional Performance
Intelligent Bio (INBS) reported total revenue of 896.77K USD in Q2 2026, with its core business segment Sales of Goods - Cartridges contributing 57.62%. Regionally, United Kingdom remained the largest market, accounting for 94.44% of total revenue. Explore Intelligent Bio's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Intelligent Bio (INBS) reported total revenue of 896.77K USD in Q2 2026, with its core business segment Sales of Goods - Cartridges contributing 57.62%. Regionally, United Kingdom remained the largest market, accounting for 94.44% of total revenue. Explore Intelligent Bio's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What guidance did Intelligent Bio's management provide for the next earnings period?What is Intelligent Bio's gross profit margin?What is the market's earnings forecast for Intelligent Bio next quarter?What is the revenue and EPS growth rate for Intelligent Bio year over year?What were the key takeaways from Intelligent Bio's earnings call?What is Intelligent Bio's latest dividend and current dividend yield?What factors drove the changes in Intelligent Bio's revenue and profit?What does Intelligent Bio do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
